Dirix L - Search Results

1

Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation.

Gerratana L, Pierga JY, Reuben JM, Davis AA, Wehbe FH, Dirix L, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, Bonotto M, Fernandez de Lascoiti A, De Mattos-Arruda L, Ignatiadis M, Sandri MT, Generali D, De Angelis C, Dawson SJ, Janni W, Carañana V, Riethdorf S, Solomayer EF, Puglisi F, Giuliano M, Pantel K, Bidard FC, Cristofanilli M. Gerratana L, et al. Among authors: dirix l. Oncologist. 2022 Jul 5;27(7):e561-e570. doi: 10.1093/oncolo/oyac045. Oncologist. 2022. PMID: 35278078 Free PMC article.

2

Circulating interleukin-6 predicts survival in patients with metastatic breast cancer.

Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck E, Huget P, Dirix LY. Salgado R, et al. Int J Cancer. 2003 Feb 20;103(5):642-6. doi: 10.1002/ijc.10833. Int J Cancer. 2003. PMID: 12494472 Free article.

3

Increased serum interleukin-8 in patients with early and metastatic breast cancer correlates with early dissemination and survival.

Benoy IH, Salgado R, Van Dam P, Geboers K, Van Marck E, Scharpé S, Vermeulen PB, Dirix LY. Benoy IH, et al. Clin Cancer Res. 2004 Nov 1;10(21):7157-62. doi: 10.1158/1078-0432.CCR-04-0812. Clin Cancer Res. 2004. PMID: 15534087

4

Genomics and circulating tumor cells: promising tools for choosing and monitoring adjuvant therapy in patients with early breast cancer?

Dirix L, Van Dam P, Vermeulen P. Dirix L, et al. Curr Opin Oncol. 2005 Nov;17(6):551-8. doi: 10.1097/01.cco.0000183669.61767.81. Curr Opin Oncol. 2005. PMID: 16224232 Review.

5

Real-time RT-PCR detection of disseminated tumour cells in bone marrow has superior prognostic significance in comparison with circulating tumour cells in patients with breast cancer.

Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpé S, Van Marck E, Vermeulen PB, Dirix LY. Benoy IH, et al. Among authors: dirix ly. Br J Cancer. 2006 Mar 13;94(5):672-80. doi: 10.1038/sj.bjc.6602985. Br J Cancer. 2006. PMID: 16495933 Free PMC article.

6

Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancer.

Benoy IH, Elst H, Philips M, Wuyts H, Van Dam P, Scharpé S, Van Marck E, Vermeulen PB, Dirix LY. Benoy IH, et al. Clin Breast Cancer. 2006 Jun;7(2):146-52. doi: 10.3816/CBC.2006.n.024. Clin Breast Cancer. 2006. PMID: 16800974 Clinical Trial.

7

Circulating tumour cell detection: a direct comparison between the CellSearch System, the AdnaTest and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer.

Van der Auwera I, Peeters D, Benoy IH, Elst HJ, Van Laere SJ, Prové A, Maes H, Huget P, van Dam P, Vermeulen PB, Dirix LY. Van der Auwera I, et al. Among authors: dirix ly. Br J Cancer. 2010 Jan 19;102(2):276-84. doi: 10.1038/sj.bjc.6605472. Epub 2009 Dec 1. Br J Cancer. 2010. PMID: 19953098 Free PMC article.

8

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.

Miles DW, Chan A, Dirix LY, Cortés J, Pivot X, Tomczak P, Delozier T, Sohn JH, Provencher L, Puglisi F, Harbeck N, Steger GG, Schneeweiss A, Wardley AM, Chlistalla A, Romieu G. Miles DW, et al. Among authors: dirix ly. J Clin Oncol. 2010 Jul 10;28(20):3239-47. doi: 10.1200/JCO.2008.21.6457. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498403 Clinical Trial.

9

Circulating tumour cells in the central and the peripheral venous compartment in patients with metastatic breast cancer.

Peeters DJ, Van den Eynden GG, van Dam PJ, Prové A, Benoy IH, van Dam PA, Vermeulen PB, Pauwels P, Peeters M, Van Laere SJ, Dirix LY. Peeters DJ, et al. Among authors: dirix ly. Br J Cancer. 2011 Apr 26;104(9):1472-7. doi: 10.1038/bjc.2011.122. Epub 2011 Apr 5. Br J Cancer. 2011. PMID: 21468046 Free PMC article.

10

mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

Sieuwerts AM, Mostert B, Bolt-de Vries J, Peeters D, de Jongh FE, Stouthard JM, Dirix LY, van Dam PA, Van Galen A, de Weerd V, Kraan J, van der Spoel P, Ramírez-Moreno R, van Deurzen CH, Smid M, Yu JX, Jiang J, Wang Y, Gratama JW, Sleijfer S, Foekens JA, Martens JW. Sieuwerts AM, et al. Among authors: dirix ly. Clin Cancer Res. 2011 Jun 1;17(11):3600-18. doi: 10.1158/1078-0432.CCR-11-0255. Epub 2011 Apr 19. Clin Cancer Res. 2011. PMID: 21505063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

443 results

Search Page